TuHURA Biosciences (HURA) Long-Term Debt Issuances (2020 - 2025)

TuHURA Biosciences' (HURA) quarterly Long-Term Debt Issuances came in at $2.9 million in Q4 2025, down 89.84% quarter-over-quarter from $28.6 million in Q3 2024.

TuHURA Biosciences (HURA) Long-Term Debt Issuances (2020 - 2025) Analysis & Trends

TuHURA Biosciences' Long-Term Debt Issuances history runs 3 years deep, the most recent figure standing at $2.9 million for Q4 2025.

  • On a quarterly basis, Long-Term Debt Issuances changed N/A year-over-year to $2.9 million in Q4 2025; TTM through Dec 2025 was $55.4 million, a N/A change from a year earlier, with the FY2025 full-year figure at $3.0 million, down 89.5% from the prior year.
  • Long-Term Debt Issuances slipped to $2.9 million in Q4 2025 per HURA's latest filing, from $28.6 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $28.6 million in Q3 2024 and bottomed at $2.9 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 TuHURA Biosciences 132.62 Mn 132.62 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 2.90 Mn
Dec 31, 2025 2.90 Mn
Sep 30, 2024 28.57 Mn
Sep 30, 2024 28.57 Mn
Jun 30, 2024 19.07 Mn
Jun 30, 2024 19.07 Mn
Mar 31, 2024 4.90 Mn
Mar 31, 2024 4.90 Mn
Sep 30, 2020 500,000.00
Sep 30, 2020 500,000.00